Susan Hasty, Publisher
Table of Contents . . . April 29th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Cell Biology - How do cells know what to do and when to do it?
Charcot-Marie-Tooth Disease - Genetic basis of hereditary nerve disorder revealed
Congestive Heart Failure - Scientists use gene therapy to restore function of damaged heart cells in lab
Myocardial Infarction - Biosensor-regulated gene therapy reduces heart attack damage in mice
Pompe Disease - Researchers use gel to deliver gene therapy to diaphragm muscle
Autism - Scientists in France announce discovery of an autism disease gene
Bacteriology - Helicobacter pylori CagA protein variation may increase risk of gastric cancer
Breast Cancer - Partners to develop breast cancer gene expression database
Cancer Therapy - Cancer-causing HDAC isoforms discussed at 2004 AACR meeting
Cancer Therapy - Data demonstrate IMO compounds inhibit tumor growth
Cancer Therapy - Data demonstrate vaccine technology's potential to treat/prevent cancer
Cancer Therapy - National Cancer Institute awards discodermolide-related grant
Cancer Therapy - Studies: Phenoxodiol produces response and restores chemosensitivity
Collaborations - Partnership to expand malaria vaccine efforts
DNA Repair - Grape seed procyanidin extract prevents DNA lesions in hepatocytes in vitro
Drug Delivery - Novel, small peptide, GA3, has potential as drug delivery ligand
Drug Discovery - Geron announces telomerase licensing agreement
Gene Medicine - Methods for production and purification of rAAV-2 vector reviewed
Head and Neck Cancer - Advexin Clinical Data presented at AACR
Oncogenesis - CBP loss causes T cell lymphomagenesis in synergy with p27(Kip1) insufficiency
Osteoporosis - Positive phase III data reported for PREOS
RNA Research - Fisher Scientific completes acquisition of RNAi technology company
SARS - NCI collaboration to investigate role of ACE2 in SARS
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.